Background: Distal medium vessel occlusions (DMVOs) and minor strokes represent emerging frontiers in mechanical thrombectomy (MT). Although several randomized clinical trials (RCTs) are underway, the design characteristics of these trials and the specific questions they aim to address have not been extensively explored. This current study sought to investigate the design and data elements reported in active prospective DMVO and minor stroke studies.
Methods: The ClinicalTrials.gov database was searched for ongoing prospective studies assessing the role of MT in patients with DMVOs or minor strokes. The Nested Knowledge AutoLit platform was utilized to categorize reported outcomes and inclusion/exclusion criteria. Frequencies of reported data elements were extracted from study protocols.
Results: A total of 10 (8 DMVO and 2 minor stroke) studies enrolling 3520 patients were included. All DMVO studies employ different criteria regarding target occlusion locations. Five DMVO studies use stent retrievers as the first-line thrombectomy technique (62.5%, 5/8), while three studies allow any MT techniques, generally at the operator's discretion. Four DMVO studies permit intravenous thrombolysis (IVT) utilization in both intervention and control arms (50%, 4/8). The DISTALS trial excludes patients receiving IVT, while the DUSK trial and Tigertriever registry only enroll patients who are ineligible for IVT or for whom IVT failed to achieve reperfusion. DMVO studies exhibit notable heterogeneity in symptom onset duration thresholds for inclusion (<6 hours: 2 studies; <12 hours: 2 studies; <24 hours: 3 studies). Minor stroke trials employ similar inclusion criteria and outcome measures except for symptom duration thresholds for inclusion (8 hours for ENDOLOW and 23 hours for MOSTE).
Conclusions: There is considerable heterogeneity among active DMVO trials regarding potential target DMVO locations and time thresholds for inclusion based on the last known well time. Furthermore, our review indicates that the utility of aspiration thrombectomy in DMVOs and the advantages of MT without IVT over IVT alone will remain largely unexplored even after completion of active DMVO trials.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1136/jnis-2023-021073 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Association of Pretreatment Perfusion Imaging Parameters With 90-Day Excellent Functional Outcomes in Anterior Circulation Distal Medium Vessel Occlusion Stroke.
AJNR Am J Neuroradiol
November 2024
From the Department of Radiology, Division of Neuroradiology, Johns Hopkins Medical Center, Baltimore, Maryland, USA (H.A.S., J.M., L.L., V.C.U., E.B.M., R.L., A.E.H., H.L., R.X., V.Y.); Department of Neuroradiology, MD Anderson Medical Center, Houston, TX 77030, USA (H.A.S., M.W.); Renaissance School of Medicine at Stony Brook University (V.V.); Department of Radiology, West Virginia University, Morgantown, WV, USA (D.A.L., A.B.); Department of Neurology, University of Cincinnati Medical Center, Cincinnati, OH (Y.A.); Neuroendovascular Program, Massachusetts General Hospital, Harvard University, Boston, MA (A.A.D.); Neurovascular Centre, Departments of Medical Imaging and Neurosurgery, St. Michael's Hospital, Toronto, ON, Canada (A.A.D.); Department of Diagnostic and Interventional Neuroradiology, Erasme University Hospital, Brussels, Belgium (A.G.); Department of Neurosurgery and Interventional Neuroradiology, Louisiana State University, LA (B.M., N.A.); Department of Radiology, Brown University, Providence, RI, USA (D.W.); Department of Interventional Neuroradiology, Stanford Medical Center, Palo Alto, California, USA (B.P.); Department of Radiology & Biomedical Imaging, University of California, San Francisco, California, USA (K.N.); Department of Neuroimaging and Neurointervention, Stanford Medical Center, Palo Alto, California, USA (J.J.H., G.W.A.); Department of Radiology, Neuroendovascular Program, University Medical Center Münster, Germany (T.D.F.).
Article Synopsis
Direct Aspiration Versus Combined Technique for Anterior Distal, Medium Vessel Occlusions Stroke: The JET Distal Vessel Occlusion Study.
Oper Neurosurg (Hagerstown)
November 2024
Radiology and Neuroradiology Department, "SS. Annunziata" Hospital, Taranto, Italy.
Background And Objectives: The optimal mechanical thrombectomy technique for distal, medium vessel occlusion (DMVO) stroke remains unknown. We aimed to compare the safety and efficacy of 2 thrombectomy first-line approaches, direct aspiration (DA), and combined technique (CT) in patients with DMVOs.
Methods: We conducted a retrospective review of a prospectively collected multicenter database of patients with DMVOs (at or distal to M2 and A1), who underwent mechanical thrombectomy with JET D reperfusion catheters between January 2020 and December 2021.
Mechanical Thrombectomy for Treatment of Acute Cerebral Infarction due to Distal Medium Vessel Occlusions: A Retrospective Cohort Study.
Brain Behav
November 2024
Department of Neurology, The Second Hospital of Dalian Medical University, Shahekou District, Liaoning, China.
Background: Mechanical thrombectomy (MT) is standard of care for acute cerebral infarction (ACI) due to large vessel occlusions. However, its clinical efficacy in patients with ACI due to distal medium vessel occlusions (DMVOs) remains unclear. This study evaluates the efficacy and safety of MT in patients with ACI due to DMVOs.
View Article and Find Full Text PDFData-Driven Prognostication in Distal Medium Vessel Occlusions Using Explainable Machine Learning.
AJNR Am J Neuroradiol
October 2024
From the Department of Neurosurgery (M.K., T.H., K.M., J.M.), and Department of Diagnostic, Molecular and Interventional Radiology (B.B.O.), Mount Sinai Health System, New York, NY, USA; Neuroendovascular Division, Department of Radiology (T.D.F.), University Medical Center Münster, Münster, Germany; Departments of Radiology and Neurosurgery (J.J.H.), Stanford University, Palo Alto, CA, USA; Department of Neuroradiology (D.A.L.), Rockefeller Neuroscience Institute, West Virginia University, Morgantown, WV, USA; Department of Radiology (K.N.), University of California San Francisco, San Francisco, CA, USA; Department of Neuroradiology (M.W.), MD Anderson Cancer Center, Houston, TX, USA; Russell H. Morgan Department of Radiology and Radiological Sciences (V.S.Y.), Johns Hopkins Medicine, Baltimore, MD, USA.
Article Synopsis
- - Distal medium vessel occlusions (DMVOs) are responsible for 25-40% of acute ischemic stroke cases, but predictive models specifically for DMVO outcomes are not yet available
- - A retrospective study developed a machine learning model using clinical, lab, imaging, and treatment data from 164 DMVO patients to predict unfavorable outcomes at 90 days, achieving good prediction accuracy and calibration
- - The model identified key predictive factors like NIHSS score and history of malignancy, and a web application was created for personalized patient outcome predictions, highlighting the potential for better stroke care and personalized medicine.
The Vecta 46 intermediate catheter for mechanical thrombectomy of distal medium vessel occlusions: A single-center experience.
Interv Neuroradiol
October 2024
John A. Burns School of Medicine, University of Hawai'i at Mānoa, Honolulu, HI, USA.
Introduction: With emerging evidence supporting the clinical efficacy and safety of mechanical thrombectomy (MT) for distal medium vessel occlusions (DMVOs), MT devices specifically designed to navigate through smaller caliber and more delicate tortuous distal cerebrovasculature are required. This study describes our single-center experience using the AXS Vecta 46 intermediate catheter for first-line thromboaspiration of DMVOs.
Methods: We identified all patients who underwent MT using the Vecta 46 for first-line thromboaspiration for primary or secondary DMVOs.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!